Age May Not Influence the Outcome of Patients with Severe Sepsis in Intensive Care Units  by Chen, Chin-Ming et al.
lable at ScienceDirect
International Journal of Gerontology 8 (2014) 22e26Contents lists avaiInternational Journal of Gerontology
journal homepage: www.i jge-onl ine.comOriginal ArticleAge May Not Inﬂuence the Outcome of Patients with Severe Sepsis
in Intensive Care Unitsq
Chin-Ming Chen 1,2*, Kuo-Chen Cheng 3,4,5, Khee-Siang Chan 2, Wen-Liang Yu 2,3
1Department of Recreation and Health Care Management, Chia Nan University of Pharmacy and Science, 2Department of Intensive Care Medicine, Chi Mei
Medical Center, 3Department of Medicine, Taipei Medical University, 4Department of Internal Medicine, Chi-Mei Medical Center, 5Department of Safety,
Health and Environment, Chung Hwa University of Medical Technology, Tainan, Taiwana r t i c l e i n f o
Article history:
Received 29 February 2012
Received in revised form
4 July 2013
Accepted 14 August 2013
Available online 7 March 2014
Keywords:
aged,
intensive care unit,
multiple organ failure,
outcomes,
severe sepsisq The authors declare that they have no ﬁnancial
interest related to the subject matter or materials dis
* Correspondence to: Chin-Ming Chen, Departmen
Chi-Mei Medical Center, 901 Chung Hwa Road, Yan
Taiwan.
E-mail address: chencm3383@yahoo.com.tw (C.-M
http://dx.doi.org/10.1016/j.ijge.2013.08.004
1873-9598/Copyright  2014, Taiwan Society of Gerias u m m a r y
Background: This study attempted to determine the association between age and outcome for severe
sepsis patients in the intensive care unit (ICU).
Methods: From May 2004 through April 2005, we conducted a prospective study of patients with severe
sepsis in eight ICUs of Chi-Mei Medical Center. Demographic and clinical information, laboratory results,
comorbidities, severity scores, mortality, and lengths of stays for both ICU and hospital were analyzed for
older (age  65 years) and younger adult (age < 65 years) patients. We analyzed the association between
age and outcome and the predictors of hospital mortality.
Results: Of the 254 patients included, 63.8% were aged 65 years. ICU and hospital mortality rates were
50.4% and 55.1%, respectively, for older and younger adult patients. Both groups had similar baseline data,
except that the older group had higher Acute Physiology and Chronic Health Evaluation (APACHE) II
scores, different comorbidities (less active cancer and alcoholism, but higher percentage of cerebral
vascular accident) and more neurologic organ failure. Older patients also had higher ICU (54.3% vs. 43.5%,
p¼ 0.097) and hospital mortality (58.0% vs. 50.0%, p¼ 0.216). Multivariate analyses showed the following
predictors of hospital mortality: being female, active cancer, septic shock, acute respiratory distress
syndrome, hematological failure, APACHE II scores >25, and inadequate drainage of infection site. Age
was not a signiﬁcant predictor for mortality after adjusting for other factors.
Conclusion: In this cohort, age was not an important predictor of mortality in ICU patients with severe
sepsis. Physicians should consider other risk factors to improve outcomes in these critically ill aged
patients.
Copyright  2014, Taiwan Society of Geriatric Emergency & Critical Care Medicine. Published by Elsevier
Taiwan LLC. All rights reserved.1. Introduction
Sepsis, a life-threatening inﬂammatory disorder, is a systemic
response of the host to infectious stimuli, and consists of clinical,
hemodynamic, and biochemical components. Severe sepsis, which
identiﬁes the most seriously ill sepsis patients, is deﬁned by the
presence of acute organ system dysfunction and remains a leading
cause of death in industrialized countries, with the number of
deaths increasing despite improved survival rates1,2. In the USA,or non-ﬁnancial conﬂicts of
cussed in the manuscript.
t of Intensive Care Medicine,
g Kang City, Tainan 71044,
. Chen).
tric Emergency & Critical Care Meapproximately 750,000 new cases of sepsis occur each year and
mortality has consistently been reported to be over 25% for severe
sepsis and as high as 70% for septic shock1,3. In Taiwan, the age-
standardized annual incidence rates of ﬁrst episodes of severe
sepsis increased by 1.6-fold from 1997 to 2006 (from 135/100,000
to 217/100,000), and the proportion of patients with multiorgan
(2) dysfunction increased from 11.7% to 27.6%4.
In most developed countries, the older adult population con-
tinues to increase to become a larger percentage of the overall
population. Since 1993, Taiwan has been designated an “aging
country” with >7% of its population aged >65 years due to ad-
vances in public health and medicine5. Use of hospital intensive
care units (ICUs) increases with age, with half of all ICU days
currently used by patients older than 65 years6. Similarly, severe
sepsis appears to be a disease of the elderly, as the mean age is
63.8 years with an increased incidence with age in the USA and adicine. Published by Elsevier Taiwan LLC. All rights reserved.
Table 1
The demographic and clinical characteristics of older (age  65 years) and younger
(age < 65 years) patients.
Characteristics All
(n ¼ 254)
Older
(n ¼ 162)
Younger
(n ¼ 92)
p
Sex (female) 95 (37.4) 67 (41.4) 28 (30.4) 0.084
Age, y 67.3  14.9 76.4  7.8 51.3  10.3 <0.001
Medical ICU 191 (75.2) 127 (78.4) 64 (69.6) 0.117
APACHE II scores 22.6  9.4 24.6  8.9 19.2  9.5 <0.001
APACHE II scores 25 113 (44.5) 83 (51.2) 30 (32.6) 0.004
SOFA scores 9.9  4.0 9.9  4.0 9.9  4.1 0.987
Comorbidities
Active cancer 32 (12.6) 15 (9.3) 17 (18.5) 0.033
Chronic steroid use 77 (30.3) 54 (33.3) 23 (25.0) 0.165
Chronic lung disease 15 (5.9) 12 (7.4) 3 (3.3) 0.178
Diabetes 108 (42.5) 67 (41.4) 41 (44.6) 0.619
Cardiovascular accident 137 (53.9) 105 (64.8) 32 (34.8) <0.001
Alcoholism 26 (10.2) 7 (4.3) 19 (20.7) <0.001
Chronic liver disease 24 (9.4) 10 (6.2) 14 (15.2) 0.841
Chronic hemodialysis 50 (19.7) 34 (21.0) 16 (17.4) 0.488
Organ failures (n) 2.8  1.4 2.8  1.4 2.8  1.4 0.806
Hematologic failure 76 (26.9) 42 (25.9) 34 (37.0) 0.065
Hepatic failure 9 (3.5) 6 (3.7) 3 (3.3) 0.854
Renal failure 90 (35.4) 56 (34.6) 34 (37.0) 0.702
Neurological failure 86 (33.9) 62 (38.4) 24 (26.1) 0.049
Metabolic dysfunction 58 (22.8) 34 (21.0) 24 (26.1) 0.068
Respiratory failure 194 (76.4) 125 (77.2) 69 (75.0) 0.352
Septic shock 199 (78.3) 125 (77.2) 74 (80.4) 0.543
ARDS 47 (18.5) 30 (18.5) 17 (18.5) 0.994
Infection source 0.212
Community-acquired 168 (66.1) 106 (65.4) 62 (67.4)
Nosocomial infection 86 (33.9) 56 (34.6) 30 (32.6)
Adequate drainage of
infection source
66 (26.0) 40 (24.7) 26 (28.3) 0.533
Ventilator days 11.9  11.4 12.2  11.3 11.4  11.4 0.583
ICU days 13.6  10.9 14.1  11.5 12.5  9.8 0.270
Hospital days 30.7  30.7 31.6  30.3 29.2  31.3 0.544
ICU mortality 128 (50.4) 88 (54.3) 40 (43.5) 0.097
Hospital mortality 140 (55.1) 94 (58.0) 46 (50.0) 0.216
Data are presented as mean  SD or n (%).
APACHE ¼ Acute Physiology and Chronic Health Evaluation; ARDS ¼ acute respi-
ratory distress syndrome; ICU ¼ intensive care unit; SOFA ¼ Sequential Organ
Failure Assessment.
Age in Patients with Severe Sepsis 23median age of 65 years in Europe7,8. Recent data showed that ICU
mortality for severe sepsis or septic shock in younger patients
(age < 60 years) was 45.6% as compared to 60.7% in older (age 60e
80 years) and 78.9% in very old (age > 80 years) patients, with
patient age an independently predictor of ICU mortality on multi-
variate analysis9. We also found that age was an important factor of
mortality on patients with unplanned and planned extubation10,11.
It was generally agreed that older persons are more prone to
infections due to the effects of aging, comorbidities, use of invasive
devices, and problems associated with institutionalization. How-
ever, we experienced that older patients may still have good clinical
outcome after appropriate rescue and therapy in our ICUs. There-
fore, the purpose of the current study was to determinate the
predictors of hospital mortality and the association between age
and outcome in older ICU patients with severe sepsis after adjust-
ing for other factors.
2. Materials and methods
2.1. Study design and patient selection
From May 1, 2004 to April 30, 2005, a prospective study was
conducted in all ICUs of Chi-Mei Medical Center, Tainan, Taiwan.
The eight ICUs had a total of 92 beds for patients aged >18 years.
The ICU staff included in-charge intensivists, respiratory therapists,
clinical nurse specialists, clinical dietitians, clinical pharmacists,
and residents, providing 24-hour coverage. The diagnostic criteria
for severe sepsis used in this study were based on an adaptation of
the operational deﬁnition developed by the Consensus Panel of the
American College of Chest Physicians and the Society of Critical
Care Medicine in 199212, deﬁned as the presence of at least two of
four criteria for systemic inﬂammatory response syndrome due to a
proven or suspected site of infection, in association with at least
one sepsis-induced organ dysfunction (Appendices 1 and 2). The
study was approved by the hospital Institutional Review Board and
all patients or their proxies gave written informed consent to
participate.
2.2. Measurements
The following data were collected: (1) demographic and clinical
variables, including age (older group, 65 years; and young group,
< 65 years), sex, origin of ICU (medical or surgical) and co-
morbidities prior to admission as modiﬁed by El-Solh et al13 (as
shown in Appendix 3); (2) severity of patient’s condition calculated
by clinical nurse specialists on ICU admission, including the Acute
Physiology and Chronic Health Evaluation (APACHE) II score, the
Sequential Organ Failure Assessment scores, the presence of acute
organ dysfunction (as deﬁned in Appendix 2) and presence of acute
respiratory distress syndrome (ARDS) as deﬁned by Bernard et al14;
(3) infection source (community or nosocomial), type of infectious
organisms, primary infection sites, and adequacy of drainage of
infection focus; and (4) outcomes, including length of time on
ventilator, length of ICU and hospital stays, and ICU and hospital
mortality.
2.3. Statistical analyses
Mean values, standard deviations, and group sizes were used to
summarize the results for continuous variables. The differences
between the older and younger group and the survival and non-
survival group at hospital discharge were examined ﬁrst by uni-
variate analysis with a Student t test and a Chi-square test. A p value
<0.05 was considered statistically signiﬁcant. Predetermined var-
iables, or those signiﬁcantly associated with hospital mortality inunivariate analysis (p < 0.05), were tested for interaction using
multiple logistic regression analysis. Odds ratios (OR) and 95%
conﬁdence intervals were calculated. Statistical analysis of the data
was done with SPSS 13.0 for Windows (SPSS, Inc., Chicago, IL, USA).3. Results
Table 1 shows the demographic and clinical characteristics of the
study population. Of the 254 patients included in the study, 37.4%
were female and 162 (63.8%) were older than 65 years, with a mean
age of 67.3 years. The ICU and hospital mortality rates were 50.4%
and 55.1%, respectively. Most patients were in amedical ICU (75.2%)
and they had amean APACHE II score of 22.6 and amean Sequential
Organ Failure Assessment score of 9.9 on the day of ICU admission.
The most common comorbidities were cardiovascular accident
(53.9%) and diabetes (42.5%). The mean number of acute organ
dysfunctions was 2.8, dominated by cardiovascular failure (septic
shock) in 78.3% of patients and respiratory failure in 76.4%. Forty-
seven patients (18.5%) were diagnosed as having ARDS. About two/
three of patients had a community-acquired infection and 26.0% of
all septic patients received adequate drainage. The mean periods of
ICU and hospital stays were 13.6 days and 30.7 days, respectively.
Youngerandolder patients had similar baseline data, except that the
older group had higher APACHE II scores (24.6  8.9 vs. 19.2  9.5)
and APACHE II scores 25 (51.2% vs. 32.6%), different comorbidities
as more possibility with cerebral vascular accident (64.8%), but less
Table 2
The types of infectious organisms found by group of patients with severe sepsis
(p ¼ 0.595).
Organism All (n ¼ 254) Older
(age  65
years; n ¼ 162)
Younger
(age < 65
years; n ¼ 92)
Gram (þ) bacteria 35 (13.8) 19 (11.7) 16 (17.4)
Gram () bacteria 141 (55.5) 92 (56.8) 49 (53.3)
Gram (þ) and () bacteria 13 (5.1) 8 (4.9) 5 (5.4)
Fungal infection 11 (4.3) 7 (4.3) 4 (4.3)
Gram (þ) and () bacteria
and fungus
2 (0.8) 2 (1.2) 0 (0)
Gram () bacteria and fungus 1 (0.4) 0 (0) 1 (1.1)
Unknown 51 (20.1) 34 (21.0) 17 (6.7)
Data are presented as n (%).
Table 3
Summary of infection sites by group of patients with severe sepsis (p ¼ 0.595).
Infections All (n ¼ 254) Older (age  65
years; n ¼ 162)
Younger
(age
< 65 years;
n ¼ 92)
Lung 124 (48.8) 83 (51.2) 41 (33.1)
Urinary tract 27 (10.6) 18 (11.1) 9 (9.8)
Abdominopelvic cavity 60 (23.6) 37 (22.8) 23 (25.0)
Primary blood stream 16 (6.3) 8 (4.9) 8 (8.7)
Others (meninges, bone
or joint, wound)
23 (9.1) 13 (8.0) 10 (10.9)
Unknown 4 (1.6) 3 (1.9) 1 (1.1)
Data are presented as n (%).
C.-M. Chen et al.24active cancer (9.3%) and alcoholism (4.3%) than the younger patients
did (34.8%, 18.5%, and 20.7%, respectively) and more neurologic or-
gan failure (38.4% vs. 26.1%). Older patients also tended to have
higher ICU (54.3% vs. 43.5%, p¼ 0.097) and hospitalmortality (58.0%
vs. 50.0%,p¼0.216). Theventilatordays, ICU stays, andhospital stays
were also insigniﬁcantly longer in the older group.
The primary infectious organisms are listed in Table 2. Analysis
showed a predominance of Gram-negative bacterial infection in
55.5% of all patients and pathogens of unknown origin in 20.1%.
Table 3 shows the primary infection sites, most frequently lung
(48.8%) and abdomino-pelvic cavity (23.6%). Multivariate analyses
revealed that the predictors for hospital mortality were being fe-
male (OR ¼ 2.214), APACHE II scores  25 (OR ¼ 1.969), having
active cancer (OR ¼ 7.244), hematological failure (OR ¼ 2.059),
ARDS (OR ¼ 2.859), or septic shock (OR ¼ 7.544) and inadequate
drainage of the infection source (OR ¼ 0.362; Table 4). Being olderTable 4
The signiﬁcant predictors of hospital mortality for all patients with severe sepsis.
Items Survivor (n ¼ 114) Nonsurv
Sex (female) 33 (28.9) 62 (44.3
APACHE II scores 25 34 (29.8) 79 (56.4
SOFA scores 8.5  3.7 11.1  3
Active cancer 6 (5.3) 26 (18.6
Chronic hemodialysis 14 (12.3) 36 (25.7
Organ failures (number) 2.5  1.3 3.0  1.4
Hematologic failure 25 (21.9) 51 (36.4
Neurological failure 31 (27.2) 55 (39.3
Metabolic dysfunction 16 (14.0) 42 (30.0
ARDS 11 (9.6) 36 (25.7
Septic shock 70 (61.4) 129 (92.
Nosocomial infection 28 (24.6) 58 (41.4
Adequate drainage of infection source 41 (36.0) 25 (19.7
Data are presented as mean  SD or n (%).
*Value for univariate analysis.
**Value for multivariate analysis.
APACHE ¼ Acute Physiology and Chronic Health Evaluation; ARDS ¼ acute respiratory dwas not an important factor for mortality after adjusting for the
other contributing factors.4. Discussion
Sepsis appears to be a disease deﬁned by age. Angus et al7 re-
ported a composite proﬁle of severe sepsis patients from 1995
hospital discharge records in seven American states with a mean
age of 63.8 years and an incidence of severe sepsis that increased
with age. Our study found a high prevalence in older patients
(63.8%) with a mean age of 67.3 years in ICU patients with severe
sepsis, compatible with studies from the USA and Europe7,8,15. In
the study of Martin et al15, older patients comprised about 12% of
the USA population, but their incidence of sepsis was as high as
64.9%, meaning that they had about a 13.1 times higher risk of
sepsis than younger patients, with case-fatality rates increasing
linearly with age. Nasa et al9 found 45.6% mortality in severe sepsis
in younger patients (age < 60 years) versus 60.7% in old (age 60e
80 years) and 78.9% in very old (age > 80 years) patients. In that
study, patient agewas an independent predictor of ICUmortality on
multivariate analysis9. We found longer ventilator use (12.2 days vs.
11.4 days), ICU stays (14.1 days vs. 12.5 days), and hospital stays
(31.6 days vs. 29.2 days) in older versus younger patients, as well as
higher ICU and hospital mortality rates (54.3% vs. 43.5% and 58.0%
vs. 50.0%, respectively, both p > 0.05), but multivariate analysis did
not show age to be a risk factor for hospital mortality. Sex (female),
severity of illness (APACHE II, ARDS, septic shock, and hematologic
failure), preadmission comorbidities (active cancer), and adequacy
of treatment seemed to be important factors determining ICU
survival (Table 4). Higher prevalence of active cancer and hema-
tologic failure in younger patients may outweigh the age impact on
mortality. The full time in-charge intensivists and multidiscipline
ICU teams with appropriate therapy in our ICUs may facilitate older
patients to have a relatively good clinical outcome.
Septic shock has been proven to be an important factor in the
mortality of sepsis patients7,16,17; in a study implementing a sepsis
protocol to lower 28-day mortality in patients with ﬂuid-refractory
septic shock, APACHE II score was a signiﬁcant predictor of mortal-
ity18; Khwannimit andBhurayanontachai19found thatbothAPACHE II
scores and ARDSwere independent risk factors for hospitalmortality
in a prospective studyof 390 patients admitted to the ICUwith severe
sepsisor septic shock.Martinet al15 found that cancerwasacomorbid
medical condition inﬂuencing outcomes in a survey of 10,422,301
adult sepsis patients. Blanco et al20 found that hematological failure
was associatedwith early death in severe sepsis patients. The presentivor (n ¼ 140) p* OR (95% CIa) p**
) 0.012 2.214 (1.177e4.164) 0.014
) <0.001 1.969 (1.068e3.631) 0.030
.9 <0.001
) 0.001 7.244 (2.251e23.314) 0.001
) 0.007
0.001
) 0.012 2.059 (1.054e4.024) 0.035
) 0.043
) 0.003
) 0.001 2.859 (1.244e6.572) 0.013
1) <0.001 7.544 (3.246e17.530) <0.001
) 0.005
) 0.001 0.362 (0.183e0.717) 0.004
istress syndrome; CI ¼ conﬁdence interval; OR ¼ odds ratio.
Appendix 3. Deﬁnition of comorbidities as modiﬁed by El-
Solh et al13
(1) Active cancer: Presence of active malignancy (solid tumor or hematologic
malignancy) at the time of presentation.
(2) Chronic steroid use: Use of steroid at a dose 20 mg/day for > 2 months.
(3) Chronic lung disease: Presence of pulmonary hypertension (mean
pulmonary arterial pressure 25 mmHg by cardiac echo or right-heart
catheterization), or if treatment is being provided for obstructive lung disease
or interstitial lung disease.
(4) Diabetes: Documented or current receipt of treatment for diabetes mellitus.
(5) Cardiovascular accident: Presence of symptomatic acute or chronic vascular
or nonvascular encephalopathy.
(6) Alcoholism: Some loss of control over drinking, with habituation or
addiction to the drug alcohol, causing interference in any major life function.
(7) Chronic liver disease: Pre-existing chronic viral hepatitis or liver cirrhosis.
(8) Chronic hemodialysis: Pre-existing end stage renal disease with
documented abnormal creatinine level with the necessity of chronic
hemodialysis.
Age in Patients with Severe Sepsis 25study found that septic shock (OR ¼ 7.544), ARDS (OR ¼ 2.859),
APACHE II 25 (OR ¼ 1.969), active cancer (OR ¼ 7.244), and hema-
tologic failure (OR ¼ 2.059) signiﬁcantly predicted mortality.
Although the incidence of sepsis is higher in men than in
women1, the idea of sex-based differences in sepsis-associated
mortality is controversial21,22. Some have posited that sex hor-
mones or sex-related gene polymorphisms may protect women
against sepsis21, but in a large cohort of 18,757 ICU patients, females
with severe sepsis or septic shock had a higher risk of dying in the
hospital than did males after multivariable adjustment22, a result
we also found. Sex-related gene polymorphisms or the effect of sex
hormones may be responsible for these different pathomechan-
isms23,24. Most importantly, we were able to demonstrate that a
sex-related effect on mortality was limited to a speciﬁc subgroup as
sepsis patients.
In our patients, the main sources of infections were pulmonary
(48.8%), abdominal (23.6%), and urinary tract (10.6%), comparable
to other studies25e27. Pure Gram-negative bacteria (55.5%) were
more common than Gram-positive bacteria (13.8%), fungal (4.3%),
or mixed infections (6.3%), in contrast to a study in Iceland that
found a more equal distribution of Gram-positive (39%), Gram-
negative (30%), and mixed (28%) infections25, but similar with a
study in Spain in which Gram-negative bacteria predominated
(50%)24. Our older patients tended to have a high prevalence of lung
infections and Gram-negative infections compared with younger
patients (51.2% vs. 33.1% and 56.8% vs. 53.3%, respectively), as
described in the literature15. Although Vesteinsdottir et al25 found
pulmonary infections to be an independent predictor of death,
Zahar et al27 found no independent association of infection site and
pathogen species with mortality. Adequate drainage of the infec-
tion source, depending on the source of infection and the pre-
morbid and current conditions of the septic patient, with drainage,
debridement, device removal, or more deﬁnitive measures such as
laparotomy, have been proved to reduce mortality in sepsis pa-
tients28, as also evidenced in our study (adequate drainage of
infection source, OR ¼ 0.362).
Our study had some limitations. First, we found a higher hos-
pital mortality rate in these ICU patients (55.1%) than reported in
most studies worldwide and in Taiwan1,3,4,7, but Nasa et al9 re-
ported similar results in their study which had a high prevalence of
older and very old individuals; similarly, Blanco et al20 found septic
shock to be more common than other reports. Our study showed
that 63.8% of patients were over 65 years and 78.3% had septic
shock. Second, we did not fully implement the resuscitation and
management bundles and calculate the completion rates, because
the guidelines of the Surviving Sepsis Campaign were published in
200429, after most of these patients had been treated. Increased
compliance has been associated with lower mortality rates30.
Our study found that being older was not a signiﬁcant predictor
of mortality for ICU patients with severe sepsis after adjusting other
factors, although older patients had worse outcomes than younger
ones. Previous reports have described different associations of age
with mortality in critically ill patients. Many other factors may also
contribute to hospital mortality, such as female sex, severity of
disease (APACHE II scores > 25, hematologic failure, ARDS, septic
shock), underlying cancer, and adequate drainage of the infection
source. Besides age, physicians should consider other possible risk
factors to help improve outcomes in such critical patients, and older
patients may still have good clinical outcome after appropriate
rescue and therapy in ICU.
Appendix 1. Disease diagnostic criteria (entry criteria)
The diagnostic criteria for severe sepsis used in this study are
based on an adaptation of the operational deﬁnition developed bythe Consensus Panel of the American College of Chest Physicians
and the Society of Critical Care Medicine10. The following detail the
disease diagnostic criteria for this study.
Proven infection:Objective identiﬁcation of a pathogenbyone or
more methods, including culture of patient specimens, Gram stain,
tissue stain, polymerase chain reaction, or other recognizedmethods.
Suspected infection: A highly suggestive clinical presentation.
Examples include pneumonia; abdominopelvic syndromes, such as
cholangitis, cholecystitis, and perforated viscus; surgical wound or
other cutaneous infection; and gross purulence, urosepsis, or pur-
pura fulminans.Appendix 2. Disease diagnostic criteria: Presence of one or
more acute organ dysfunction
(1) Cardiovascular (septic shock):Hypotension in the absence of
causes other than sepsis. For example, an arterial systolic blood
pressure of 90 mmHg; a mean arterial pressure 70 mmHg
for at least 1 hour despite adequate ﬂuid resuscitation;
>40 mmHg drop in systolic blood pressure from baseline; or
the need for vasoactive agents to maintain systolic blood
pressure 90 mmHg or mean arterial pressure 70 mmHg.
(2) Respiration: Acute lung injury due to sepsis and associated
with serious hypoxemia. For example, O2 saturation<90% on
room air, PaO2  70 mm Hg, or PaO2/FiO2  280.
(3) Renal: Oliguria (average urine output <0.5 mL/kg/hour for
1 hour despite adequate ﬂuid resuscitation; <30 mL/hour for
3 hours or < 700 mL/24 hours; or creatinine  2 times the
upper limit of normal; or the need for renal replacement
therapy as a result of severe sepsis.
(4) Hematology: Thrombocytopenia, e.g., platelet count
<100  1012/L or 50% decrease in platelet count from the
highest value recorded over the past 3 days.
(5) Unexplained metabolic acidosis: Both (i) pH  7.30 or base
deﬁcit 5.0 mEg/L; and (ii) a plasma lactate level> 1.5 times
the upper limit of normal for the reporting laboratory.
Measurement of PH or base deﬁcit and lactate level should
occur within a clinically relevant time interval such that a
causal relationship exists between the measured values.
(6) Neurological: Evidence of encephalopathy with, for
example, a Glasgow Coma Scale score of <13.
(7) Hepatic:Markedly increased serum bilirubin level (bilirubin
>3 times the upper limit of normal), clinical jaundice, or
prothrombin time international normalized ratio > 3.0 due
to sepsis.
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